The relationship of the methylenetetrahydrofolate reductase C6(77)T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy

Basit Öğe Kaydı
dc.contributor.authorEroglu, Z.
dc.contributor.authorErdogan, M.
dc.contributor.authorTetik, A.
dc.contributor.authorKaradeniz, M.
dc.contributor.authorCetinalp, S.
dc.contributor.authorKosova, B.
dc.contributor.authorSev, C. G. D. Correlated With Hyperhomocysteinemia The
dc.contributor.authorGunduz, C.
dc.contributor.authorOzgen, A. G.
dc.contributor.authorYilmaz, C.
dc.date.accessioned2019-10-27T19:59:22Z
dc.date.available2019-10-27T19:59:22Z
dc.date.issued2007
dc.departmentEge Üniversitesien_US
dc.description.abstractBackground Poor glycaemic control, hypertension and duration of diabetes are risk factors for the development of diabetic nephropathy, but there may be genetic factors. Recently, a common C to T mutation at nucleotide position 677 of the MTHFR gene (MTHFR677C>T) has been reported to be correlated with hyperhomocysteinemia and the severity of coronary artery disease as macroangiopathy. We aim to investigate Turkish type 2 diabetic patients with/without diabetic nephropathy and healthy group and examine the contribution of the MTHFR gene polymorphism to the development of diabetic nephropathy. Methods DNA was extracted from peripheral leukocytes of the subjects. Genotyping of the MTHFR C677T polymorphism for all individuals was performed by melting curve analysis of the generated amplicons after realtime online PCR. Results This genotype distribution did not differ between control subjects and type 2 diabetic patients in which 6.8% were TT, 43.7% were CT and 49.5% were CC (chi(2) = 0.201, p > 0.05). The frequency of the mutant T allele was 23.4% in diabetic patients with nephropathy versus 33.0% in those without nephropathy. The genotype frequencies were TT, 2.1%; CT, 46.6%; CC, 55.3% in diabetic patients with nephropathy versus TT, 10.7%; CT, 44.6%; CC, 44.6% in those without nephropathy. Conclusions The MTHFR genotype and allele frequencies were not different between diabetic patients with and without nephropathy (chi(2) = 3, 386, p > 0.005; chi(2) = 2.320, p > 0.005, respectively). Therefore, we conclude that the MTHFR gene polymorphism is not associated with the development of diabetic nephropathy in Turkish type 2 diabetic patients. Copyright (D 2007 John Wiley & Sons, Ltd.en_US
dc.identifier.doi10.1002/dmrr.735en_US
dc.identifier.endpage624en_US
dc.identifier.issn1520-7560
dc.identifier.issue8en_US
dc.identifier.pmid17354258en_US
dc.identifier.startpage621en_US
dc.identifier.urihttps://doi.org/10.1002/dmrr.735
dc.identifier.urihttps://hdl.handle.net/11454/41174
dc.identifier.volume23en_US
dc.identifier.wosWOS:000251441300004en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofDiabetes-Metabolism Research and Reviewsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectpolymorphism of methylenetetrahydrofolate reductaseen_US
dc.subjectdiabetic nephropathyen_US
dc.subjecttype 2 diabetesen_US
dc.titleThe relationship of the methylenetetrahydrofolate reductase C6(77)T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu